Trans-neuronal viral tracing is becoming one of the most important methods for mapping neuronal circuit connections, but an anterograde trans-synaptic tracer compatible with functional assays is still lacking.
Adeno-associated virus (AAV) is replication-defective, and its production of offspring needs the help of adenovirus (AV) [1] or herpesvirus co-infection [2] . The replication deficiency, non-pathogenicity, easy manipulability, and broad tissue tropism make AAV a widely-used genetransfer vector for expressing target genes.
The viral particle of AAV has no envelope. The nucleocapsid contains a single-stranded DNA genome of 4.7 kb, consisting of two open reading frames encoding replication (Rep) and capsid (Cap) proteins, flanked by two 145-base inverted terminal repeats, which allow for synthesis of the complementary DNA strand [3] . The Rep and Cap genes are essential for the production of AAV particles, but are not necessary for gene expression in cis [4] . Thus, when AAV is used as a gene-transfer vector, the transgene cassette with its own promoter is inserted between the two inverted terminal repeats, and the replaced Rep and Cap genes are complementarily supplied in trans together with other required AV genes (E4, E2a, and VA) for viral particle production. The resulting AAV is a replicationdeficient pseudovirus that expresses target gene(s) in host cells but is incapable of replicating and spreading [4, 5] .
Many AAV serotypes and the corresponding AAV vectors display neuronal tropism; these include AAVs 1, 2, 4, 5, 8, and 9. Besides introducing target genes into the central nervous system for gene therapy or target-gene expression for functional studies, AAV is also used for probing neuronal connectivity and dissecting circuit functions, including wide use in optogenetics and chemogenetics. AAV expressing fluorescent proteins has been used most often to visualize the physical axonal localization between two brain regions rather than the actual functional connection. But recent studies have suggested that AAV1 is also transported anterogradely down the axon [6, 7] . The investigation by Zingg et al. showed that AAV can be used for anterograde transsynaptic tagging [8] .
AAV entry via endocytosis and its axonal transport have been documented [6, 7] . However, the trans-synaptic transmission of AAV has been neglected by most researchers. By injecting AAV expressing Cre recombinase (Cre) into the central nervous system of Ai14 transgenic mice (Cre-dependent tdTomato reporter), Zingg et al. demonstrated that AAV1 and AAV9 trans-neuronally transduced the postsynaptic neuron, in which AAVexpressed Cre led to tdTomato expression and thus visualization of the cell [8] . This anterograde trans-synaptic tagging is an important improvement of the AAV applications, and complements the current viral tracers for analyzing neuronal circuits. ([10  13 genome copies/mL), which probably results in an overload and spillover of virus particles (Fig. 1) . (4) Relatively low efficiency. The replication-defective virus cannot amplify itself, and thus the efficiency of trans-neuronal tagging is low. The requirement for a high virus titer and the low efficiency of transneuronal tagging make the labeling reproducibility a considerable concern.
In summary, this study proposed a promising novel application of AAV as a potential anterograde tracer, which may greatly facilitate mapping direct output maps and input-defined subpopulations as well as revealing their functions. the cell follow the process described in A (solid lines). But the overloaded AAV capsids cannot all be uncoated and express the target gene in the initially-infected neurons. Thus, the uncoated virus is transported anterogradely along the axons to the terminal and released from the synapse, then re-enter the adjacent postsynaptic neurons, and expresses the target transgene at lower incidence (dashed lines).
